FXIa inhibitor as a promising new anticoagulant drug

3' education - Nov. 23, 2021 - Prof. Jeffrey Weitz, MD - Hamilton, ON, Canada

Educational information

This video was recorded during the American Heart Association’s Scientific Sessions 2021.

Faculty

Dr. Weitz is Professor of Medicine and Biochemistry and Biomedical Sciences at McMaster University and Executive Director of the Thrombosis and Atherosclerosis Research Institute in Hamilton, ON, Canada.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Read our summary of the AXIOMATRIC-TKR study

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.